TrialBritish journal of clinical pharmacology2010

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).

Simon R Sinclair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.